Latest News about AVXL
Recent news which mentions AVXL
From Benzinga
15 Biggest Mid-Day Gainers For Thursday
September 22, 2016
From Benzinga
From Benzinga
15 Stocks Moving In Thursday's Pre-Market Session
September 22, 2016
From Benzinga
12 Biggest Mid-Day Losers For Tuesday
September 13, 2016
From Benzinga
3 Stocks to Avoid in the Biotechnology Sector
September 10, 2016
From Motley Fool
Anavex Confirms Phase 2a Trial Data Of ANAVEX 2-73 In Alzheimer's Patients Presented At AAIC
July 29, 2016
Tickers
AVXL
From Benzinga
12 Stocks Moving In Wednesday's Pre-Market Session
June 22, 2016
From Benzinga
From Benzinga
From Benzinga
Anavex Leife Sciences +24% Premarket @$6.50; May be Attributed to Report on Australian Alzheimer's Trial
April 25, 2016
Tickers
AVXL
From Benzinga
From Benzinga
10 Stocks Moving In Friday's Pre-Market Session
April 08, 2016
From Benzinga
Anavex Gets FDA Approval For Orphan Drug Designation for Frontotemporal Dementia Treatment
April 08, 2016
Tickers
AVXL
From Benzinga
10 Stocks Moving In Thursday's Pre-Market Session
March 10, 2016
From Benzinga
Anavex Life Sciences Erases 5% Gain, Company Released Of Encouraging Preclinical Results
February 25, 2016
Tickers
AVXL
From Benzinga
Markets plunge over $30 crude oil
February 02, 2016
Lower open even as crude oil rebounds
January 13, 2016
Oil falls below $31 but markets close higher
January 12, 2016
From Benzinga
Mid-Day Market Update: US Stocks Turn Lower; Affymetrix Shares Surge On Acquisition News
January 11, 2016
From Benzinga
Higher open after last week’s rout
January 11, 2016
From Benzinga
Anavex Announces Positive Dose-Response Data for ANAVEX 2-73 in Alzheimer's Disease Patients
January 10, 2016
Tickers
AVXL
From Benzinga
Lower open a pending home sales slip
December 30, 2015
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.